| SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination R Pajon, NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, ... New England Journal of Medicine 386 (11), 1088-1091, 2022 | 392 | 2022 |
| mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant VV Edara, KE Manning, M Ellis, L Lai, KM Moore, SL Foster, K Floyd, ... Cell Reports Medicine 3 (2), 2022 | 212 | 2022 |
| Comprehensive analysis of COVID-19 during pregnancy KM Moore, MS Suthar Biochemical and Biophysical Research Communications 538, 180-186, 2021 | 154 | 2021 |
| Booster of mRNA-1273 strengthens SARS-CoV-2 Omicron neutralization NA Doria-Rose, X Shen, SD Schmidt, S O’Dell, C McDanal, W Feng, ... MedRxiv, 2021 | 89 | 2021 |
| Sustained delivery of doxorubicin via acetalated dextran scaffold prevents glioblastoma recurrence after surgical resection E Graham-Gurysh, KM Moore, AB Satterlee, KT Sheets, FC Lin, ... Molecular pharmaceutics 15 (3), 1309-1318, 2018 | 55 | 2018 |
| Synergistic drug combinations for a precision medicine approach to interstitial glioblastoma therapy EG Graham-Gurysh, AB Murthy, KM Moore, SD Hingtgen, EM Bachelder, ... Journal of Controlled Release 323, 282-292, 2020 | 42 | 2020 |
| Tumor responsive and tunable polymeric platform for optimized delivery of paclitaxel to treat glioblastoma EG Graham-Gurysh, KM Moore, AN Schorzman, T Lee, WC Zamboni, ... ACS applied materials & interfaces 12 (17), 19345-19356, 2020 | 39 | 2020 |
| Metal–organic coordination polymer for delivery of a subunit broadly acting influenza vaccine M Eckshtain-Levi, CJ Batty, LM Lifshits, B McCammitt, KM Moore, ... ACS applied materials & interfaces 14 (25), 28548-28558, 2022 | 28 | 2022 |
| Injectable, ribbon-like microconfetti biopolymer platform for vaccine applications KM Moore, CJ Batty, R Stiepel, CJ Genito, EM Bachelder, KM Ainslie ACS Applied Materials & Interfaces, 2020 | 22 | 2020 |
| Polymeric biomaterial scaffolds for tumoricidal stem cell glioblastoma therapy KM Moore, AB Murthy, EG Graham-Gurysh, SD Hingtgen, EM Bachelder, ... ACS Biomaterials Science & Engineering 6 (7), 3762-3777, 2020 | 18 | 2020 |
| Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: reactivity to vaccine antigen and variants of concern RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ... MedRxiv, 2022.01. 03.22268599, 2022 | 14 | 2022 |
| Impact of composite scaffold degradation rate on neural stem cell persistence in the glioblastoma surgical resection cavity KM Moore, EG Graham-Gurysh, HN Bomba, AB Murthy, EM Bachelder, ... Materials Science and Engineering: C 111, 110846, 2020 | 13 | 2020 |
| Contrasting behavior between the three human monocyte subsets in dengue pathophysiology D Maheshwari, K Saini, P Singh, M Singla, K Nayak, C Aggarwal, ... IScience 25 (6), 2022 | 11 | 2022 |
| Flexible, microstructured surfaces using chitin-derived biopolymers S Pradhan, KM Moore, KM Ainslie, VK Yadavalli Journal of Materials Chemistry B 7 (35), 5328-5335, 2019 | 11 | 2019 |
| Rapid Detection and Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Variant in a Returning Traveler ME Sexton, JJ Waggoner, LR Carmola, PV Nguyen, E Wang, D Khosravi, ... Clinical Infectious Diseases 75 (1), e350-e353, 2022 | 8 | 2022 |
| Humoral response to the acetalated dextran M2e vaccine is enhanced by antigen surface conjugation CJ Batty, ES Pena, EA Amouzougan, KM Moore, KM Ainslie, ... Bioconjugate Chemistry 34 (8), 1447-1458, 2023 | 6 | 2023 |
| Single-cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells KM Moore, AN Pelletier, S Lapp, A Metz, GK Tharp, M Lee, SS Bhasin, ... Journal of Virology, e00194-24, 2024 | 5 | 2024 |
| Contrasting behavior between the three human monocyte subsets in dengue pathophysiology. iS-cience 25 D Maheshwari, K Saini, P Singh, M Singla, K Nayak, C Aggarwal, ... | 3 | 2022 |
| Polymeric Biomaterial Drug Delivery Systems for Glioblastoma Therapy and Vaccines KM Moore The University of North Carolina at Chapel Hill, 2020 | 1 | 2020 |
| Eosinophils protect against SARS-CoV-2 following a vaccine breakthrough infection KM Moore, SL Foster, EJ Elrod, KA Floyd, ME Williams, M Kar, ... bioRxiv, 2024.08. 08.607190, 2024 | | 2024 |